ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 19, 2017 | $2,020,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 23, 2017 | $1,455,000 | Yes |
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANJULEN ANDERSON REILLY | — |
| BRUCE ARTIM | — |
| HARRISON C COOK | — |
| SEAN DONOHUE | — |
| CATHERINE HINCKLEY | — |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| JESSE SEVCIK | — |
| SONYA SOTAK ELLING | — |
| JOHN STEELE | — |
| ERIC J. STEINER | — |
| DAVID TALBOT | — |
Agriculture AGR
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANJULEN ANDERSON REILLY | — |
| JESSE SEVCIK | — |
| ERIC J. STEINER | — |
Copyright/Patent/Trademark CPT
Intellectual property; MODDERN cures
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| JESSE PRICE | — |
| SONYA SOTAK ELLING | — |
Medicare/Medicaid MMM
Intellectual property; MODDERN Cures; Dormant Therapies Act; 340B Program; Medicare Part B and Part D; PPACA; IPAB repeal
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| SEAN DONOHUE | — |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
Consumer Issues/Safety/Products CSP
Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (UNHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| SEAN DONOHUE | — |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
Torts TOR
Trade secret/theft protection coalition
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
Taxation/Internal Revenue Code TAX
Tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| SEAN DONOHUE | — |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
Health Issues HCR
Patient protection; Drug shortages; Drug pricing and value; Dormant Therapies Act; PDUFA; BSUFA; RACE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | — |
| SEAN DONOHUE | — |
| JOE KELLEY | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
| DAVID TALBOT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.